Vineet Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.
VINEETLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vineet Laboratories' board, at its May 12, 2025 meeting, approved the audited standalone financial results for Q4 and FY25, reported with an unmodified (unqualified) opinion from statutory auditors NSVR & Associates LLP. The board re-appointed Mr. Dilip Vishnu Acharekar (DIN: 08849689) as an Independent Director for a second 5-year term (Nov 16, 2025 to Nov 15, 2030), subject to shareholder approval. It also recommended appointing P S Rao & Associates as Secretarial Auditor for a 5-year period (FY 2025-26 to FY 2029-30). The company also disclosed its qualified borrowings data, confirming it is not classified as a Large Corporate. The auditor's report included an emphasis-of-matter note on a Rs. 7.12 crore write-off of slow-moving and obsolete inventory identified during physical verification.
Shareholders should note the company reported a net loss of Rs. 20.19 crore for FY25 (EPS of Rs. -21.90) against a small profit of Rs. 1.03 crore in FY24, with revenue nearly halving to Rs. 75 crore. The Rs. 7.12 crore obsolete inventory write-off is a key red flag. The director re-appointment and secretarial auditor appointment are routine governance items, but the sharp deterioration in financial performance is likely to weigh on the stock price.